Compare iShares MSCI Germany (DAX) (EWG) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs Recursion Pharmaceuticals Inc — how do they compare? iShares MSCI Germany (DAX) trades at $43.99, while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: iShares MSCI Germany (DAX) is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| EWG | RXRX | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $44.56 | $6.79 |
52-Week Low | $38.08 | $2.84 |
Market Cap | — | $1.81B |
Enterprise Value | — | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG trades at $44.02, up 1.15% today, with a bullish technical signal from moving averages but bearish oscillators indicating overbought conditions. Key support and resistance cluster at $44. A dividend of $0.83 is scheduled for June 2026. Recent news highlights European Central Bank rate decisions and German economic policies influencing regional markets.
The outlook is mixed; technical strength suggests near-term upside, but high RSI levels warn of pullback risks. European regulatory and economic developments remain critical drivers. Investors face volatility from monetary policy shifts and energy price fluctuations, requiring careful monitoring of ECB actions and German fiscal measures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
